Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte

• 来源期刊: 生物医学研究杂志（英文版）
• 学科: 医学
• 年，卷（期）: 2017,（2）
• 页码范围: 95-107
• 页数: 13页
• 分类号: R587.1
• 语种: 英文
• DOI: 10.7555/JBR.31.20160139

摘要

The liver directs cholesterol metabolism in the organism.All the major fluxes of cholesterol within the body involve the liver:dietary cholesterol is directed to the liver;cholesterol from peripheral cells goes to the liver;the liver is a major site of cholesterol synthesis for the organism;cholesterol is secreted from the liver within the bile,within apoB lipoproteins and translocated to nascent HDL.The conventional model of cholesterol homeostasis posits that cholesterol from any source enters a common,rapidly exchangeable pool within the cell,which is in equilibrium with a regulatory pool.Increased influx of cholesterol leads rapidly to decreased synthesis of cholesterol.This model was developed based onin vitro studies in the fibroblast and validated only for LDL particles.The challenges the liver must meet in vivo to achieve cholesterol homeostasis are far more complex.Our model posits that the cholesterol derived from three different lipoproteins endosomes has three different fates:LDL-derived cholesterol is largely recycled within VLDL with most of the cholesterol shunted through the hepatocyte without entering the exchangeable pool of cholesterol;high density lipoprotein-derived CE is tmnscytosed into bile;and chylomicron remnant-derived cholesterol primarily enters the regulatory pool within the hepatocyte.These endosomal channels represent distinct physiological pathways and hepatic homeostasis represents the net result of the outcomes of these distinct channels.Our model takes into account the distinct physiological challenges the hepatocyte must meet,underlie the pathophysiology of many of the apoB dyslipoproteinemias and account for the sustained effectiveness of therapeutic agents such as statins.